OCUL Annual Shareholders Equity
$91.13 M
+$55.75 M+157.59%
31 December 2023
Summary:
As of January 23, 2025, OCUL annual stockholders equity is $91.13 million, with the most recent change of +$55.75 million (+157.59%) on December 31, 2023. During the last 3 years, it has risen by +$15.04 million (+19.76%). OCUL annual shareholders equity is now at all-time high.OCUL Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OCUL Quarterly Shareholders Equity
$352.02 M
-$25.67 M-6.80%
30 September 2024
Summary:
As of January 23, 2025, OCUL quarterly stockholders equity is $352.02 million, with the most recent change of -$25.67 million (-6.80%) on September 30, 2024. Over the past year, it has increased by +$344.17 million (+4382.63%). OCUL quarterly shareholders equity is now -13.72% below its all-time high of $407.98 million, reached on March 31, 2024.OCUL Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OCUL Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +157.6% | +4382.6% |
| 3 y3 years | +19.8% | +303.1% |
| 5 y5 years | +154.0% | +3014.9% |
OCUL Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +157.6% | -13.7% | >+9999.0% |
| 5 y | 5-year | at high | +2610.5% | -13.7% | +3402.6% |
| alltime | all time | at high | +253.2% | -13.7% | +607.0% |
Ocular Therapeutix Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $352.02 M(-6.8%) |
| June 2024 | - | $377.69 M(-7.4%) |
| Mar 2024 | - | $407.98 M(+347.7%) |
| Dec 2023 | $91.13 M(+157.6%) | $91.13 M(+1060.5%) |
| Sept 2023 | - | $7.85 M(+154.4%) |
| June 2023 | - | $3.09 M(-68.2%) |
| Mar 2023 | - | $9.71 M(-72.6%) |
| Dec 2022 | $35.38 M(-59.8%) | $35.38 M(-23.5%) |
| Sept 2022 | - | $46.23 M(-29.7%) |
| June 2022 | - | $65.80 M(-17.5%) |
| Mar 2022 | - | $79.80 M(-9.3%) |
| Dec 2021 | $88.00 M(+15.6%) | $88.00 M(+0.8%) |
| Sept 2021 | - | $87.34 M(+8.8%) |
| June 2021 | - | $80.25 M(-3.8%) |
| Mar 2021 | - | $83.41 M(+9.6%) |
| Dec 2020 | $76.09 M(-2196.3%) | $76.09 M(-1944.3%) |
| Sept 2020 | - | -$4.13 M(-177.2%) |
| June 2020 | - | $5.34 M(-150.1%) |
| Mar 2020 | - | -$10.66 M(+193.6%) |
| Dec 2019 | -$3.63 M | -$3.63 M(-132.1%) |
| Sept 2019 | - | $11.30 M(+36.8%) |
| June 2019 | - | $8.26 M(-67.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $25.65 M(-28.5%) |
| Dec 2018 | $35.88 M(+37.2%) | $35.88 M(-21.2%) |
| Sept 2018 | - | $45.52 M(-0.5%) |
| June 2018 | - | $45.73 M(-7.0%) |
| Mar 2018 | - | $49.18 M(+88.1%) |
| Dec 2017 | $26.15 M(-49.7%) | $26.15 M(-27.2%) |
| Sept 2017 | - | $35.92 M(-25.2%) |
| June 2017 | - | $48.02 M(-24.8%) |
| Mar 2017 | - | $63.91 M(+22.9%) |
| Dec 2016 | $52.01 M(-41.9%) | $52.01 M(-16.5%) |
| Sept 2016 | - | $62.29 M(-11.6%) |
| June 2016 | - | $70.45 M(-12.1%) |
| Mar 2016 | - | $80.17 M(-10.5%) |
| Dec 2015 | $89.59 M(+52.6%) | $89.59 M(-9.3%) |
| Sept 2015 | - | $98.81 M(-9.4%) |
| June 2015 | - | $109.11 M(+109.5%) |
| Mar 2015 | - | $52.07 M(-11.3%) |
| Dec 2014 | $58.70 M(-198.7%) | $58.70 M(-10.5%) |
| Sept 2014 | - | $65.60 M(-194.5%) |
| June 2014 | - | -$69.44 M(-722.9%) |
| Mar 2014 | - | $11.15 M(-118.7%) |
| Dec 2013 | -$59.47 M(+27.6%) | -$59.47 M |
| Dec 2012 | -$46.61 M | - |
FAQ
- What is Ocular Therapeutix annual stockholders equity?
- What is the all time high annual shareholders equity for Ocular Therapeutix?
- What is Ocular Therapeutix annual shareholders equity year-on-year change?
- What is Ocular Therapeutix quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Ocular Therapeutix?
- What is Ocular Therapeutix quarterly shareholders equity year-on-year change?
What is Ocular Therapeutix annual stockholders equity?
The current annual shareholders equity of OCUL is $91.13 M
What is the all time high annual shareholders equity for Ocular Therapeutix?
Ocular Therapeutix all-time high annual stockholders equity is $91.13 M
What is Ocular Therapeutix annual shareholders equity year-on-year change?
Over the past year, OCUL annual stockholders equity has changed by +$55.75 M (+157.59%)
What is Ocular Therapeutix quarterly stockholders equity?
The current quarterly shareholders equity of OCUL is $352.02 M
What is the all time high quarterly shareholders equity for Ocular Therapeutix?
Ocular Therapeutix all-time high quarterly stockholders equity is $407.98 M
What is Ocular Therapeutix quarterly shareholders equity year-on-year change?
Over the past year, OCUL quarterly stockholders equity has changed by +$344.17 M (+4382.63%)